METHOD FOR SURGICAL TREATMENT OF RETINAL DETACHMENT WITH PERIPHERAL RUPTURE BY BLOCKING THE RUPTURE WITH A DROP OF BLOOD AUTOPLASMA Russian patent published in 2020 - IPC A61F9/07 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely ophthalmosurgery. For surgical treatment of retinal detachment with peripheral rupture of retina 3-port vitrectomy 25-27G of valve type is performed with separation and removal of posterior hyaloid membrane, plugging the vitreal cavity, blocking the retinal rupture by applying a drop of blood platelet-rich autoplasma on the ruptured region. Tamponade of the vitreal cavity is performed intraoperatively, and after the operation, a balanced salt solution (BSS) is left in the vitreal cavity; for this purpose, after the vitrectomy, the balanced salt solution is partially replaced with a perfluororganic compound (PFOC). PFOC is introduced to the lower edge of the retinal rupture; after that, the subretinal fluid is drained through the rupture until the retina completely adjoins; then the BSS solution located above the PFOC is replaced with air. Further, the pressure in the vitreal cavity is lowered to mild hypotension, and then, from the outside, the sclera is pressed into the peripheral rupture by the standard sclerocompressor, bringing the retina into a horizontal position in the air medium and continuing sclerocompression. On the retinal rupture located on a horizontal area, using a syringe a drop of blood platelet-rich autoplasma in amount of 0.05–0.1 ml is placed, after that the remaining volume of air in the vitreal cavity is replaced with PFOC. PFOC tamponade is maintained for 2–3 minutes. That is followed by stopping sclerocompression, performing endolaser coagulation of the retina around the rupture and replacing the PFOC with the BSS solution.

EFFECT: method enables eliminating peripheral rupture of the retina, wherein in the postoperative period the patient does not need to be face down for a long time.

3 cl, 1 ex